These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1626163)

  • 1. [Internistic therapy possibilities in therapy-resistant Crohn disease].
    Hoffmann R
    Schweiz Rundsch Med Prax; 1992 Jun; 81(26):866-8. PubMed ID: 1626163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive therapy of aspecific types of enterocolitis].
    Bläker F; Schäfer KH
    Klin Padiatr; 1983; 195(1):13-6. PubMed ID: 6682159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy of steroid-resistant Crohn's disease.
    Sands BE
    Can J Gastroenterol; 2000 Sep; 14 Suppl C():33C-37C. PubMed ID: 11023559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does adjuvant nutritional support diminish steroid dependency in Crohn disease?
    Verma S; Holdsworth CD; Giaffer MH
    Scand J Gastroenterol; 2001 Apr; 36(4):383-8. PubMed ID: 11336163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elemental diet in steroid-dependent and steroid-refractory Crohn's disease.
    O'Brien CJ; Giaffer MH; Cann PA; Holdsworth CD
    Am J Gastroenterol; 1991 Nov; 86(11):1614-8. PubMed ID: 1951239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 7. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
    Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
    Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe and steroid-resistant Crohn's disease.
    Michetti P; Mottet C; Juillerat P; Pittet V; Felley C; Vader JP; Gonvers JJ; Froehlich F
    Digestion; 2007; 76(2):99-108. PubMed ID: 18239400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe and steroid-resistant Crohn's disease.
    Michetti P; Mottet C; Juillerat P; Felley C; Vader JP; Burnand B; Gonvers JJ; Froehlich F
    Digestion; 2005; 71(1):19-25. PubMed ID: 15711044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of Crohn's disease with cyclosporine: the effect of a very low dose on maintenance of remission.
    Lobo AJ; Juby LD; Rothwell J; Poole TW; Axon AT
    J Clin Gastroenterol; 1991 Feb; 13(1):42-5. PubMed ID: 2007743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should we treat Crohn's disease?
    Sleisenger MH
    N Engl J Med; 1980 May; 302(18):1024-6. PubMed ID: 6102738
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G; Israel DM; Hassall E
    Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Crohn's disease with azathioprine or 6-mercaptopurine. Retrospective study of 126 cases].
    Lémann M; Bonhomme P; Bitoun A; Messing B; Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1990; 14(6-7):548-54. PubMed ID: 2397863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.